Webinar: On Target: Enhancing Immunotherapies by LabX Media Group

Host Login

About This Webinar

A plethora of immunotherapies, including immune checkpoint inhibitors, T-cell therapy, monoclonal antibodies, and immune system modulators, have been developed in the past several decades to treat growing global incidences of cancer. However, these therapies are not without risk. This webinar will highlight innovative immunotherapeutic strategies using genetic engineering approaches that modify a patient's own immune cells to more precisely target cancers, while concurrently minimizing the risk of adverse responses.

Presenters

Sandro Matosevic, PhD

Assistant Professor, Industrial and Physical Pharmacy, Purdue University

Sandro Matosevic is an assistant professor in the Department of Industrial and Physical Pharmacy at Purdue University. He is also a member of the Purdue Center for Cancer Research. Sandro obtained his graduate degree from University College London and completed his postdoctoral training at the Scripps Research Institute. His independent research is focused on the development and use of natural killer cells in the treatment of solid cancers. Matosevic is on the editorial board of several journals and has been on committees and advisory boards of several organizations advancing the development and standardization of cell-based therapies, including the International Society for Cell & Gene Therapy.

Chris DeRenzo, MD, MBA

Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children’s Research Hospital

Chris DeRenzo is a pediatric oncologist who joined the Department of Bone Marrow Transplantation and Cellular Therapy at St. Jude Children's Research Hospital in 2018, where he works to translate promising cell therapies into clinical trials for pediatric patients with solid tumors and brain tumors. He went to college at Rutgers University and medical school at Rutgers, Robert Wood Johnson Medical School, both in New Jersey. He then performed general pediatric training at Case Western Reserve University in Cleveland, Ohio, and pediatric hematology/oncology training at Baylor College of Medicine/Texas Children’s Hospital in Houston, Texas, where he stayed on as faculty until transitioning to St. Jude. DeRenzo grew up in Southern New Jersey, outside of Philadelphia. While he never imagined moving to Cleveland, Houston, or Memphis, he’s enjoyed living in each of these great cities, and getting to know people from all over the United States and around the world.